Clinical Trial

Validation of the Montreal Cognitive Assessment (MoCA) Version 8.x and MoCA-MIS in Greece.

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 22, 2025 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Objective: The purpose of this study is to assess the psychometric qualities of the Montreal Cognitive Assessment (MoCA) version 8.x in Greek, including the MoCA-MIS. We intend to examine the tool's reliability (internal consistency, test-retest reliability) and validity (construct validity, concurrent validity, and known-group validity). Aim: The findings will support the tool's application for early cognitive impairment identification in clinical and research settings.
Trial Details
NCT Number NCT07297121
Lead Sponsor Aristotle University Of Thessaloniki
Collaborators: MoCA Clinic and Institute
Conditions MCI, Dementia, Mild Cognitive Impairment (MCI)
Enrollment 250 participants
Start Date 2026-01-01
Primary Completion 2026-06-01 (estimated)
Study Completion 2027-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-22